Skip to content
54

nicotinamide riboside

Worth a look

Shows low returns (0.1%), but a small market ($78K/yr) keeps it on the watch list.

Market size 20Growth 21Conversion 55Competition 41Returns 100Price range 89Avg price 95Brand share 71Review moat 84Quality gap 58

Returns

Incredible0.1%

return rate — above 5% kills the launch gate

Avg price

Incredible€27.61

avg listing price — sweet spot $15–$100

Price range

Great€11.50–€58.08

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Great310.38

avg incumbent reviews — the moat a new listing must climb

Brand share

Good62%

top-5 brand share — brands hold most of the demand

Quality gap

Good4.4★

avg incumbent rating — lower means beatable quality

Conversion

Good4.6%

search→purchase rate — share of searches ending in a sale

Competition

Okay60%

top-5 click share — leaders hold, buyers still browse

Growth

Bad-8.4%

90-day search growth — must beat 0% to launch

Market size

Bad€78K

€78K/yr · 61K searches

Trend